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Summary
Introduction—Little is known about the extent to which the age at which asthma first began 
influences respiratory health later in life. We conducted these analyses to examine the relationship 
between age at asthma onset and subsequent asthma-related outcomes.
Methods—We used data from 12,216 adults with asthma who participated in the 2010 
Behavioral Risk Factor Surveillance System Asthma Call-back Survey to describe the distribution 
of age at asthma onset. Linear regression was used to estimate associations of age at asthma onset 
with asthma-related outcomes, including symptoms in the past 30 days and asthma-related 
emergency visits.
Results—Asthma onset before age 16 was reported by an estimated 42% of adults with active 
asthma, including 14% with onset at 5–9 years of age who reported experiencing any asthma 
symptoms on 21% of days in the past month. Compared to this group, the percentage of days in 
the past month with any asthma symptoms was 14.8% higher (95% confidence interval (CI): 5.4, 
24.1) among those whose asthma onset occurred at <1 year. When age at onset occurred at 10 
years or older there was little change in the prevalence of asthma-related emergency visits across 
age at onset categories.
Conclusion—Age at asthma onset may affect subsequent asthma-related outcomes.
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Introduction
Asthma affects a growing proportion of the population around the world [1]. In the United 
States, the estimated prevalence of asthma increased from 7.3% in 2001 to 8.4% in 2010, 
with higher prevalences reported among children aged 0–17 than among adults [2]. The 
coughing, wheezing, chest tightness, and difficulty breathing that are characteristic of 
asthma can begin at any age and may persist throughout life, [3–5] though little is known 
about the extent to which the age at which asthma first began is associated with the 
presence, frequency, or severity of subsequent respiratory health outcomes. If the age at 
asthma onset is associated with respiratory outcomes later in life, then improving our 
understanding of these associations may increase our ability to introduce educational, 
environmental, and clinical interventions at an age at which they may be most effective. 
Data from the Behavioral Risk Factor Surveillance System (BRFSS) Asthma Call-back 
Survey provide a unique opportunity to describe the distribution of age at asthma onset 
among adults with active asthma and examine associations between age at asthma onset and 
subsequent asthma-related outcomes among adults in the United States.
Methods
Asthma Call-back Survey
We conducted these analyses using data from the 2010 BRFSS Asthma Call-back Survey. 
BRFSS is an ongoing, state-based, random-digit-dialed telephone survey of 
noninstitutionalized men and women aged 18 years and older residing in the United States 
[6,7]. In 2010, the BRFSS survey sample was based on disproportionate stratified sampling 
of landline telephones from strata of high density and medium density of known household 
telephone numbers in 50 states, the District of Columbia, Guam, Puerto Rico, and the U.S. 
Virgin Islands [8]. Additional detailed information about the multistage sampling design and 
sample weighting used for BRFSS is available elsewhere [6,7,9]. The Asthma Call-back 
Survey is a follow-up telephone survey conducted approximately two weeks after BRFSS 
interviews among respondents in who indicated that they have ever had asthma by 
responding ‘yes’ to the following question: “have you ever been told by a doctor, nurse, or 
other health professional that you had asthma?” In 2010, the National Asthma Control 
Program provided funding to 37 states, the District of Columbia, and Puerto Rico to conduct 
the Asthma Call-back Survey. The 37 states are: Alabama, Arizona, California, Connecticut, 
Florida, Georgia, Hawaii, Illinois, Indiana, Iowa, Kansas, Louisiana, Maine, Maryland, 
Massachusetts, Michigan, Mississippi, Missouri, Montana, Nebraska, Nevada, New 
Hampshire, New Jersey, New Mexico, New York, North Dakota, Ohio, Oklahoma, Oregon, 
Pennsylvania, Rhode Island, Texas, Utah, Vermont, Washington, West Virginia, and 
Wisconsin. In 2010, ever having a history of asthma was reported by 42,584 BRFSS 
respondents in the subset of 37 states, the District of Columbia, and Puerto Rico; of these 
BRFSS respondents, 17,753 responded to the Asthma Call-back Survey. The Council of 
American Survey and Research Organization [10] response rates among participating areas 
ranged from 34% to 64% (overall: 49%; median: 50%) [11]. The BRFSS Asthma Call-back 
Survey is exempt from Institutional Review Board (IRB) review at the Centers for Disease 
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Control and Prevention; state-specific IRB requirements apply to each of the participating 
states, the District of Columbia, and Puerto Rico.
Study sample
For this analysis, we present results based on analysis of data from 12,216 respondents with 
active asthma (Fig. 1). As in previous analysis of Asthma Call-back Survey data [12], 
respondents were categorized as having active asthma if they reported that at least one of the 
following occurred during the past 12 months: talked to a doctor or other health professional 
about [his/her] asthma, took asthma medication, or experienced any symptoms of asthma. 
Our final group of selected respondents is limited to those who provided an age at asthma 
onset, current age, and time since asthma onset; whose responses regarding age at asthma 
onset, current age, and time since asthma onset were consistent; and for whom information 
about smoking status and race/ethnicity was not missing.
Age at asthma onset
We used responses to the following questionnaire item, “how old were you when you were 
first told by a doctor or other health professional that you had asthma?” to indicate the ages 
at which respondents’ asthma began (hereafter referred to as “age at asthma onset”). We 
categorized the distribution of age, in years, at asthma onset: <1, 1–4, 5–9, 10–14, 15–19, 
20–24, 25–29, 30–34, 35–39, 40–44, 45–49, 50–54, 55–59, 60–64, 65–69, 70–74, and 75–
92.
Asthma-related outcomes
The frequency of current symptoms was evaluated using responses to two items: “during the 
past 30 days, on how many days did you have any symptoms of asthma?”; and “during the 
past 30 days, on how many days did symptoms of asthma make it difficult for you to stay 
asleep?”. For both outcomes, we calculated the percentage of days with each outcome 
during the time period by dividing the response by 30 days and multiplying by 100.
The degree to which respondents experienced exacerbations of their asthma was evaluated 
to indicate the severity of the asthma-related outcomes using responses to three 
questionnaire items: “during the past 12 months, have you had an episode of asthma or an 
asthma attack?”; “during the past 12 months, have you had to visit an emergency room or 
urgent care center because of your asthma?”; and “during the past 12 months, that is since 
[one year ago today], have you had to stay overnight in a hospital because of your asthma?”. 
For all outcomes, we considered uninformative responses (i.e., don’t know, missing, 
refused) to be negative responses.
Other covariates
Demographic covariates shown include current age, race/ethnicity, and sex. Health-related 
covariates include cigarette smoking status, history of chronic obstructive pulmonary disease 
(COPD), history of angina or coronary heart disease, and time since asthma diagnosis. 
Cigarette smoking status was categorized as current smoker who smokes every day, current 
smoker who smokes some days, former smoker, and lifetime nonsmoker. Respondents who 
reported ever being told by a doctor or health professional that they had COPD, emphysema, 
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or chronic bronchitis were identified as having a history of COPD. Respondents who 
reported ever being told that they had angina or coronary heart disease were identified as 
having a history of angina or coronary heart disease. Respondents reported the time since 
being diagnosed with asthma as less than one year, one to five years, or more than five 
years.
Statistical analysis
Demographic and health-related characteristics are presented for the sample of respondents 
and the weighted population estimate. In each age at onset category, asthma-related 
outcomes are presented as weighted, unadjusted percentages, with standard errors (SE). 
Associations between age at asthma onset and the asthma-related outcomes were estimated 
using linear regression and are presented as percent differences (PD), with 95% confidence 
intervals (CI). For each outcome, associations were estimated using a single model in which 
the prevalence of the asthma outcome was evaluated in each category of age at asthma 
onset, with the referent category of 5–9 years. The age category of 5–9 years was selected as 
a referent group because of the large size of the actual sample and estimated population in 
this category. PDs are interpreted as the absolute difference between the percentages of the 
outcome in a given category of age at onset and in the referent category. All models 
included 16 indicator variables for the categories of age at asthma onset, accounted for the 
survey sampling methods, and were adjusted for age as a continuous variable, race/ethnicity, 
sex, smoking status, time since asthma onset, history of COPD, and history of angina or 
coronary heart disease.
For weighted population estimates, we used sampling weights provided with the Asthma 
Call-back Survey data to account for BRFSS and Asthma Call-back Survey nonresponse and 
unequal sampling probabilities. We conducted the analyses using procedures for analysis of 
complex sample survey data in SAS version 9.3 (SAS Institute Inc., Cary, North Carolina, 
USA) and used the Taylor series method [10,11] to estimate variance under the sampling 
conditions (i.e., sampling with replacement) used in the BRFSS Asthma Call-back Survey 
[13]. To properly account for the complex sample survey design [14], we retained the entire 
sample (n = 17,753) in our final analyses and present only the results generated from the 
stratum consisting of our selected population of 12,216 respondents.
Following our final analysis, we conducted separate analyses to evaluate the sensitivity of 
our results to two decisions made in creating our final study sample: categorizing 754 
individuals with uninformative (i.e., don’t know, missing, and refused) responses to the 
asthma outcome questionnaire items as not having the relevant outcomes and including 1682 
respondents whose asthma onset occurred within the last five years.
Results
Table 1 presents the demographic and health-related characteristics of the 12,216 adults with 
active asthma in our final study sample and the estimated 17.6 million adults represented by 
the survey sample. The sample included adult men and women aged 18–99 years. An 
estimated 42% of adults with active asthma reported the onset of asthma as occurring before 
the age of 16; in this group, asthma onset occurred at a mean age of 7 years (SE: 0.2). In the 
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remaining group with onset at age 16 or older, asthma onset occurred at a mean age of 38 
years (SE: 0.3). An estimated 87% of adults with active asthma reported that the onset of 
asthma occurred more than five years ago.
The distribution of age at asthma onset in the actual sample and estimated populations and 
adjusted PDs generated for the two metrics of the frequency of asthma symptoms are shown 
in Table 2; mean reported frequencies of the two outcomes for the entire estimated 
population and across categories of age at asthma onset are shown in Fig. 2. Overall, low 
mean percentages of the past 30 days with any symptoms of asthma (mean: 21%; SE: 1.9) 
and with asthma symptoms that made it difficult to stay asleep (mean: 8%; SE: 1.4) were 
observed among respondents who reported asthma onset at age 5–9 years. Relative to this 
referent group, the adjusted estimate of the percentage of the past 30 days with any 
symptoms of asthma was 14.8% higher (95% CI: 5.4, 24.1) and the adjusted estimate of the 
percentage of the past 30 days with symptoms that made it difficult to stay asleep was 8.1% 
higher (95% CI: 1.1, 15.0) among those who reported the onset as occurring before 1 year of 
age.
Table 3 show estimated percentages of adults with active asthma reporting an episode or 
attack of asthma in the past 12 months, an emergency department or urgent care center visit 
for asthma in the past 12 months, and an overnight hospital stay in the past 12 months 
because of asthma. The prevalence of each of the three outcomes declined notably across the 
three categories of increasing age at asthma onset before 10 years of age (Fig. 2). However, 
when asthma onset occurred at 10 years or older, there was little change in the prevalence of 
emergency or urgent care visits or overnight hospital stays across categories of age at onset. 
Adjusted estimates of the association between age at asthma onset and experiencing 
episodes or attacks of asthma during the past 12 months were lowest among adults whose 
asthma onset occurred at age 50 or older, compared to those whose onset occurred at 5–9 
years (Table 3).
We conducted a secondary set of analyses that excluded respondents with uninformative 
responses (i.e., don’t know, missing, refused) to asthma outcome questions. In our final 
study sample, these 754 respondents represent 4.2% (95% CI: 3.3, 5.1) of the estimated 
population. The percentage of the estimated population with uninformative responses to 
specific asthma outcome questionnaire items ranged from 0.2% (95% CI: 0.1, 0.4) for 
responses about emergency room or urgent care center visits to 1.9% (95% CI: 1.4, 2.4) for 
responses about asthma symptoms that made it difficult to stay asleep. In analyses that 
excluded these respondents, results were similar to those presented in Tables 2 and 3. 
Restricting our analyses to respondents whose asthma onset occurred five or more years ago 
generated adjusted estimates similar to those generated in our main analyses (data not 
shown).
Discussion
Our findings indicate that among adults with active asthma, the age at which asthma began 
may be associated with subsequent exacerbations of asthma. Most notably, among adults 
who self-reported asthma onset as occurring before 15 years of age, the highest percentage 
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of the past 30 days with symptoms and the highest percentage of respondents with 
emergency or urgent care visits occurred among those whose asthma onset occurred at less 
than 1 year. For several of the outcomes we evaluated, little variation in the magnitude of 
the outcomes was observed across categories of adult-onset asthma until age at onset 
reached late adulthood. Among those whose onset occurred at older ages, the observed 
increases in the percentage of respondents who reported experiencing an episode or attack of 
asthma, emergency or urgent care visits, or hospitalizations for asthma in the past 12 months 
may reflect more severe asthma in older adults, a lower level of control among recently 
diagnosed individuals, the presence of co-morbidities resulting in emergency visits 
attributed to asthma, or a combination of conditions or circumstances that lead to increased 
severity of asthma among older adults. Our estimates of the prevalence of asthma outcomes 
among adults whose asthma onset occurred at older ages should therefore be interpreted 
with caution.
Metrics of the severity of asthma, asthma control, and COPD have each been associated 
with health-related quality of life [15–17] and asthma has been associated with accelerated 
lung function decline over time. [18–20] Recent epidemiologic evidence that decreased lung 
function may be a predictor of cardiovascular morbidity and mortality [21–26] suggests that 
changes in the prevalence of asthma may have large impacts on the health of aging 
populations. We found that the frequency and severity of respiratory outcomes may be 
associated with the age at which asthma onset occurs and that the lowest occurrences of 
these outcomes are generally observed among individuals whose asthma onset occurred at 
ages 5–9 years. These findings support evidence that among children with wheezing 
symptoms, the timing of onset may be associated with subsequent asthma outcomes [27], 
and extend these findings by assessing asthma-related outcomes in later life and across a 
wide range of ages at onset. Our findings reveal opportunities for further investigation of the 
role of age at asthma onset in determining behaviors, such as using medication, recognizing 
and avoiding symptom triggers, or communicating with health care personnel, which may 
influence respiratory health outcomes. If children who were first told that they had asthma 
when they were 5–9 years old developed better asthma self-management skills than children 
who whose onset occurred during infancy and whose asthma was managed to a greater 
extent by their parents, then our findings reveal important opportunities to examine 
educational approaches to asthma management. Similarly, our findings suggest that if 
respiratory infections during early life or other factors associated with the onset of asthma 
are also associated with the age at asthma onset, then such factors may also be associated 
with asthma-related outcomes in later life. However, our ability to draw conclusions about 
the etiology of early asthma onset or the relationship between etiologic risk factors and 
asthma outcomes in later life is limited by our use of cross-sectional surveillance data.
Our findings should be interpreted carefully. The 2010 Asthma Call-back Survey represents 
adults in 37 U.S. states, the District of Columbia, and Puerto Rico and these data should not 
be considered nationally representative. In addition, 2010 Asthma Call-back Survey 
respondents self-reported their asthma status, onset, and current respiratory-related outcomes 
in interviewer-administered landline telephone surveys and we were unable to verify or 
validate the information provided. Analysis of the extent to which self-reported asthma and 
age at asthma onset may be affected by differential recall has indicated that while reports of 
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age at asthma onset are generally accurate, self-reported asthma status may vary by asthma 
severity – that is, individuals with mild asthma may be less likely to report their asthma 
during a follow-up interview [28]. If the 2010 Asthma Call-back Survey data were affected 
by such a bias in the reporting of asthma status, then adults with mild asthma may be under-
represented in our sample. The accuracy with which adults self-report age at asthma onset, 
particularly when onset occurred during infancy or early childhood, is also unknown. 
Evaluation of the relationship between asthma severity and self-reported age at asthma onset 
in data sources that include documentation of onset would improve our understanding of the 
relationship between age at asthma onset and subsequent asthma outcomes. Likewise, if 
adults with a history of smoking, symptoms of COPD, or other conditions that affect their 
breathing incorrectly attributed their outcomes to asthma, then asthma-related exacerbations 
may be over-reported in the Asthma Call-back Survey.
Our final models are adjusted for smoking status and history of COPD, angina, or coronary 
heart disease, however, our results, particularly those generated for older age at onset 
categories, should be interpreted with caution. If older adults with COPD are systematically 
misdiagnosed with new-onset asthma or self-report the onset of asthma, then our results do 
not accurately represent the respiratory health status of older adults with asthma. Cautious 
interpretation is also warranted because of the collinearity between current age, age at 
asthma onset, and time since onset. The sensitivity analyses in which we restricted our final 
study sample to respondents who reported that asthma onset occurred five or more years ago 
differentially excluded older respondents and those whose asthma occurred at older ages, but 
did not affect the interpretation of our results. Our results are based on linear regression 
models, which are typically robust to violations of assumptions about the variance of the 
response. Nonetheless, our assessment of the data for its compatibility with linear regression 
methods indicated that older age categories may be affected by outliers or non-normally 
distributed residuals that limit further justify caution in interpreting the results generated for 
older age at onset categories. However, such violations must be extreme to generate large 
biases [29] and without further justification for restricting our analysis to younger adults, we 
have opted to present findings across the entire range of age groups represented by these 
data. In addition, restricting our analyses to 11,846 respondents with valid metrics of body 
mass index and adjusting our final models for body mass index did not suggest confounding 
of the relationship between age at asthma onset and the asthma-related outcomes by body 
mass index (data not shown).
Our description of asthma-related outcomes by age at asthma onset and our findings of 
variation in asthma-related symptoms and unexpected health care visits due to asthma across 
categories of age at onset, particularly across younger age categories, are novel. Age at 
asthma onset is often reported as occurring before or after a relevant age [30–32]. Our 
descriptive presentation of age at asthma onset suggests that when the burden of asthma-
related outcomes is of interest, differences in age at onset should be considered carefully. 
The degree to which variations in the asthma-related outcomes evaluated here are due to 
biological or behavioral factors remains unclear. If the age at asthma onset affects the 
manner in which a patient learns how to manage and treat symptoms of asthma, then our 
findings reveal opportunities to examine how this knowledge may be used to improve 
asthma management and subsequent respiratory health outcomes.
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Figure 1. 
Selection of the study sample: 2010 BRFSS Adult Asthma Call-back Survey. aThe 2010 
BRFSS was conducted in 50 states, the District of Columbia, Guam, Puerto Rico, and the 
U.S. Virgin Islands. bThe 2010 Adult Asthma Call-back Survey was conducted in 37 states, 
the District of Columbia, and Puerto Rico. In 2010, 42,584 BRFSS respondents in the 37 
states, the District of Columbia, and Puerto Rico reported ever having asthma. A dashed line 
is used to indicate that Asthma Call-back Survey respondents are not representative the 
60,744 BRFSS respondents with asthma and therefore a percentage is not shown.
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Figure 2. 
Percentage of days in the past 30 that respondents reported experiencing any asthma 
symptoms or difficulty staying asleep because of asthma symptoms (above). Percentage of 
respondents who reported an episode or attack of asthma in the past 12 months, an 
emergency department or urgent care center visit for asthma in the past 12 months, and an 
overnight hospital stay in the past 12 months because of asthma (below).
Mirabelli et al. Page 11
Respir Med. Author manuscript; available in PMC 2015 July 23.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Mirabelli et al. Page 12
Table 1
Demographic and health-related characteristics of the study sample: 2010 BRFSS Adult Asthma Call-back 
Survey.
Actual samplea Weighted population estimate
No. No. Percent (95% CI)
Total 12,216 17,552,107 –
Demographic characteristics
Race/ethnicity
 White, non-Hispanic 9724 12,900,295 73.5 (71.6, 75.4)
 Black, non-Hispanic 973 1,685,590 9.6 (8.3, 10.9)
 Other, non-Hispanic 818 1,066,762 6.1 (5.2, 7.0)
 Hispanic 701 1,899,460 10.8 (9.3, 12.4)
Sex
 Male 3226 6,445,183 36.7 (34.6, 38.8)
 Female 8990 11,106,924 63.3 (61.2, 65.4)
Health-related characteristics
Age at asthma onset, in years
 <16 3456 7,402,854 42.2 (40.0, 44.3)
 ≥16 8760 10,149,253 57.8 (55.7, 60.0)
History of COPD
 No 7100 11,661,818 66.4 (64.6, 68.3)
 Yes 5116 5,890,289 33.6 (31.7, 35.4)
History of angina or coronary heart disease
 No 10,926 16,367,525 93.3 (92.4, 94.1)
 Yes 1290 1,184,582 6.7 (5.9, 7.6)
Smoking status
 Current smoker, smokes every day 1455 2,269,536 12.9 (11.6, 14.3)
 Current smoker, smokes some days 626 838,642 4.8 (4.0, 5.6)
 Former smoker 4202 4,787,711 27.3 (25.6, 28.9)
 Lifetime non-smoker 5933 9,656,219 55.0 (53.0, 57.0)
Time since asthma onset
 <1 Year 389 555,899 3.2 (2.4, 4.0)
 1–5 Years 1293 1,774,826 10.1 (9.0, 11.3)
 >5 Years 10,534 15,221,383 86.7 (85.4, 88.1)
aUnweighted sample.
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